Literature DB >> 12684387

Molecular therapeutics: is one promiscuous drug against multiple targets better than combinations of molecule-specific drugs?

Carlos L Arteaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12684387

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

Review 1.  Pazopanib: a novel multitargeted tyrosine kinase inhibitor.

Authors:  Guru Sonpavde; Thomas E Hutson
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

2.  Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.

Authors:  Stanley F Barnett; Deborah Defeo-Jones; Sheng Fu; Paula J Hancock; Kathleen M Haskell; Raymond E Jones; Jason A Kahana; Astrid M Kral; Karen Leander; Ling L Lee; John Malinowski; Elizabeth M McAvoy; Debbie D Nahas; Ronald G Robinson; Hans E Huber
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.